GlucoTrack, Inc. (GCTK)

NASDAQ: GCTK · USD

$2.03

+0.32 (+18.7%)· Recorded snapshot

Market cap	2.4M
Net income (ttm)	-15.9M
EPS (ttm)	-$226
Shares out	1.2M
Volume	27,803,424
Beta	0.73

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -15.9M
EPS (ttm): -$226
Market cap: 2.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 13.4P50 20.2P75 35.7

Trailing P/En/a

P25 15.4P50 25.8P75 43.5

ROE-620.6

P25 -113.8P50 -46.5P75 -0.9

ROIC-261.4

P25 -68.5P50 -27.1P75 1.8

Benchmarks · 1M

All GCTK indicators

Market & fundamental data

Available fields

178

Groups with data

Currency

USD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001506983
Company name	GlucoTrack, Inc.
Country	United States
Country code	US
CUSIP number	45824Q879
Earnings date	2026-11-12
Earnings time	amc
Employees	15
Employees change	4
Employees growth	36.36%
Enterprise value	$3.2M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2001
Industry	Medical Devices
Is primary listing	Yes
Is SPAC	No
ISIN number	US45824Q8794
Last 10-K release date	2026-03-30
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2026-10-26
Last stock split type	Reverse
Market cap	$2.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$2.03
Price currency	USD
Sector	Healthcare
SIC code	3841
Stock price date	2026-10-28
Symbol	GCTK
U.S. state	New Jersey
Website	https://glucotrack.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-11,110.79%
FCF / EV yield	-570.24%
FCF yield	-805.4%
Industry forward P/E	19.81x
Industry P/E	39.28x
Sector forward P/E	23.56x
Sector P/E	50.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	$-1.1M
ROA	-164.45%
ROA (5Y)	-105.67%
ROCE	1,031.41%
ROE	-620.63%
ROIC	-261.35%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	6
EPS growth years	1
Net income growth quarters	4
Net income growth years	1
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-87,000
Depreciation and amortization	$66,000
EBIT	$-15.4M
EBITDA	$-15.3M
EPS	$-225.55
FCF per share	$-13.77
Financing cash flow	$7.9M
Free cash flow	$-16.3M
Free cash flow minus SBC	$-16.7M
Investing cash flow	$-87,000
Net borrowing	$4.4M
Net cash flow	$-8.4M
Net income	$-15.9M
Operating cash flow minus SBC	$-16.6M
Operating income	$-15.4M
Stock-based compensation	$373,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$-8.34
Interest coverage	-125.2
Long-term assets	$114,000
Long-term liabilities	$248,000
Net cash (debt)	$-835,000
Net cash / market cap	-41.24%
Piotroski F-Score	0
Property, plant and equipment	$114,000
Shareholders' equity	$-1.7M
Tangible book value	$-1.7M
Tangible book value per share	$-8.34
Total assets	$1.5M
Total cash	$1.1M
Total debt	$2M
Total liabilities	$3.2M
WACC	6.63%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$1.4M
Current liabilities	$3M
Current ratio	0.46
Net working capital	$-1M
Quick ratio	0.38
Working capital	$-1.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y price change	-100%
10Y return CAGR	-77.42%
10Y total return	-100%
150-day SMA	$12.78
1D price change	18.71%
1M price change	-43.96%
1M total return	-43.96%
1W price change	56.68%
1W total return	56.66%
1Y price change	-98.98%
1Y return CAGR	-98.98%
1Y total return	-98.98%
20-day SMA	$1.85
200-day SMA	$24.43
3M price change	-77.62%
3M total return	-77.62%
3Y price change	-99.99%
3Y return CAGR	-96.19%
3Y total return	-99.99%
50-day SMA	$4.60
50-day SMA vs 200-day SMA	50under200
52-week high	$225.00
52-week high date	2025-10-28
52-week low	$0.75
52-week low date	2026-10-23
5Y price change	-100%
5Y return CAGR	-92.53%
5Y total return	-100%
6M price change	-90.59%
6M total return	-90.59%
All-time high	$23,397,285.92
All-time high date	2013-05-13
All-time low	$0.75
All-time low date	2026-10-23
Average true range (ATR)	$0.53
Average volume	3.4M
Beta (1Y)	2.93
Beta (2Y)	2.45
Beta (5Y)	0.73
Change from 52-week high	-99.1%
Change from 52-week low	172.19%
Change from all-time high	-100%
Change from all-time low	173.53%
Change from open	2.01%
Day's gap	16.37%
Dollar volume	$56.4M
High price	$2.49
Low price	$1.80
Monthly RSI	32.2
Open price	$1.99
Position in 52-week range	33.33%
Premarket change	17.54%
Premarket close	$1.71
Premarket price	$2.01
Premarket volume	12.2M
Previous close	$1.71
Price vs 150-day SMA	-84.04%
Price vs 20-day SMA	10.15%
Price vs 200-day SMA	-91.65%
Price vs 50-day SMA	-55.68%
Relative volume	8.1
RSI	42.02
Sharpe ratio	-0.96
Sharpe ratio (3Y)	-0.69
Sharpe ratio (5Y)	-0.35
Sortino ratio	-2
Sortino ratio (3Y)	-1.17
Sortino ratio (5Y)	-0.68
Volume	27.8M
Weekly RSI	29.36
YTD price change	-98.24%
YTD total return	-98.24%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	360K
Float percentage	30.41%
Shares change (QoQ)	205.78%
Shares held by insiders	1.7%
Shares held by institutions	5.2%
Shares outstanding	1.2M
Short % of float	33.91%
Short % of shares	10.31%
Short ratio	0 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	566

Deeper analysis on GCTK

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this GCTK report

Is a complete GCTK research report available?

No complete published report is available for GlucoTrack, Inc. (GCTK) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

GlucoTrack, Inc. (GCTK)

Price

Financial snapshot

Fair-value bridge

Latest news · GCTK

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GCTK indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on GCTK

Frequently asked questions